Managing xylazine-involved overdoses in a community harm reduction setting: lessons from Tijuana, Mexico
Abstract Background Xylazine is a α2-adrenergic receptor agonist, used for sedation in veterinary contexts. Although it is increasingly found in overdose deaths across North America, the clinical management of xylazine-involved overdoses has not been extensively studied, especially in community-base...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-01-01
|
| Series: | Harm Reduction Journal |
| Online Access: | https://doi.org/10.1186/s12954-024-01143-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|